Calendar NeoGenomics, Inc.

Equities

NEO

US64049M2098

Delayed Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
15.72 USD +3.42% Intraday chart for NeoGenomics, Inc. +1.81% -2.84%

Chart calendar NeoGenomics, Inc.

2a657f3f4abbc20128.UcdBc_f_ZPjLiXPmo30RVo_xcLlWeWoC9mUGx4Qe7nU.I6JyEbaZEZb54QuRlDZ2OfvJJvY7OwR3m1VTsPdZjxAZlxk9gtIskfL_Sw~21c85283b9ea21f5815951f894f43e23

Upcoming events on NeoGenomics, Inc.

2024-04-07 04:30 pm American Association for Cancer Research Meeting - Poster No:30
2024-04-07 04:30 pm American Association for Cancer Research Meeting - Poster No:17
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Poster No:26
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Poster No:30
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:8
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Poster No:35
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Poster No:10
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Poster No:30
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Poster No:16
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Poster No:5
2024-04-10 12:00 pm American Association for Cancer Research Meeting - Poster No:20
2024-04-29 Q1 2024 Earnings Release (Projected)
2024-07-29 Q2 2024 Earnings Release (Projected)
2024-10-28 Q3 2024 Earnings Release (Projected)
2025-02-24 Q4 2024 Earnings Release (Projected)

Past events on NeoGenomics, Inc.

2024-03-05 09:10 am TD Cowen Health Care Conference
2024-02-20 04:30 pm Q4 2023 Earnings Call
2024-02-20 04:05 pm Q4 2023 Earnings Release
2024-01-08 08:15 pm JPMorgan Healthcare Conference
2023-11-29 09:00 am Piper Sandler Healthcare Conference
2023-11-06 04:30 pm Q3 2023 Earnings Call
2023-11-06 04:05 pm Q3 2023 Earnings Release
2023-08-08 08:30 am Q2 2023 Earnings Call
2023-08-08 07:00 am Q2 2023 Earnings Release
2023-06-14 02:20 pm Goldman Sachs Global Healthcare Conference
2023-06-05 02:15 pm American Society of Clinical Oncology Conference - Abstract Number: 6065
2023-06-04 09:00 am American Society of Clinical Oncology Conference - Abstract Number: 9019
2023-06-04 09:00 am American Society of Clinical Oncology Conference - Abstract Number: 601
2023-06-04 09:00 am American Society of Clinical Oncology Conference - Abstract Number: 8535
2023-06-04 09:00 am American Society of Clinical Oncology Conference - Abstract Number: TPS620
2023-06-02 03:45 pm American Society of Clinical Oncology Conference - Abstract Number: 502
2023-05-25 10:00 am Annual General Meeting
2023-05-10 02:20 pm Bank of America Healthcare Conference - Fireside Chat
2023-05-08 04:30 pm Q1 2023 Earnings Call
2023-05-08 04:05 pm Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
409
406
0.66%
444
443
0.44%
484
485
-0.06%
510
501
1.72%
592
589
0.47%

655

EBITDA
Million USD
Released
Forecast
Spread
57,2
57,5
-0.45%
34,8
33,1
5.34%
-4,16
-2,03
-104.55%
-48,0
-59,2
18.87%
3,49
-2,22
256.78%

22,7

EBIT
Million USD
Released
Forecast
Spread
13,0
14,8
-12.1%
-14,0
-11,3
-24.31%
-119
-101
-17.11%
-158
-163
3.4%
-108
-105
-2.56%

-85,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
3,65
3,82
-4.51%
-14,1
-18,3
23.21%
-15,1
-3,98
-278.65%
-159
-172
7.52%
-97,1
-104
6.51%

-79,6

Net income
Million USD
Released
Forecast
Spread
8,01
3,52
127.49%
4,17
-8,48
149.22%
-8,35
0,68
-1325.95%
-144
-158
8.6%
-88,0
-93,9
6.31%

-72,0

EPS
USD
Released
Forecast
Spread
0,08
0,04
122.22%
0,04
-0,08
150.79%
-0,07
0,00
-4091.62%
-1,16
-1,27
8.66%
-0,70
-0,75
6.04%

-0,57

Announcement Date27/02/2024/02/2123/02/2223/02/2320/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
126
126
-0.03%
117
116
0.62%
125
123
1.47%
129
122
5.96%
139
130
6.72%
137
126
8.58%
147
137
6.91%
152
142
7.01%
156
153
1.98%

150


163


168


174


166

EBITDA
Million USD
Released
Forecast
Spread
-9,79
-6,72
-45.53%
-19,0
-20,0
4.76%
-16,3
-18,8
13.37%
-11,6
-18,9
38.98%
-1,17
-11,7
90.06%
-7,12
-12,5
42.85%
-2,05
-8,34
75.4%
3,31
-3,14
205.27%
9,35
3,43
172.21%

-0,57


4,26


6,44


12,4


5,20

EBIT
Million USD
Released
Forecast
Spread
-41,6
-29,3
-41.95%
-52,0
-40,8
-27.49%
-39,7
-41,5
4.23%
-39,5
-40,3
1.89%
-26,4
-36,7
28.18%
-35,1
-36,1
2.87%
-29,9
-31,5
5.06%
-24,2
-27,7
12.63%
-18,6
-21,3
12.79%

-27,5


-22,6


-20,4


-15,1


-22,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-44,2
-33,4
-32.39%
-53,2
-43,2
-23%
-41,0
-45,1
8.99%
-39,6
-44,2
10.29%
-25,5
-38,5
33.65%
-33,7
-39,3
14.27%
-26,6
-33,0
19.27%
-21,5
-29,3
26.8%
-15,3
-21,8
29.93%

-25,6


-21,2


-19,3


-14,4


-20,3

Net income
Million USD
Released
Forecast
Spread
-41,8
-33,3
-25.55%
-49,4
-42,8
-15.33%
-35,3
-42,1
16.08%
-36,9
-41,8
11.77%
-22,7
-36,3
37.42%
-30,8
-35,9
14.28%
-24,3
-30,0
18.98%
-18,5
-26,7
30.76%
-14,3
-20,0
28.24%

-23,7


-19,1


-17,3


-12,7


-18,2

EPS
USD
Released
Forecast
Spread
-0,34
-0,27
-25.15%
-0,40
-0,35
-15.94%
-0,28
-0,34
16.95%
-0,30
-0,33
9.43%
-0,18
-0,29
38.2%
-0,25
-0,29
12.28%
-0,19
-0,24
20%
-0,15
-0,21
29.05%
-0,11
-0,16
30.16%

-0,19


-0,15


-0,14


-0,10


-0,14

Announcement Date23/02/2227/04/2209/08/2208/11/2223/02/2308/05/2308/08/2306/11/2320/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise